Table 3

Effect of intervention on primary and secondary endpoints

Outcomes

3-Day Routine Change

Group

(n = 177)

Clinically Indicated Change Group

(n = 185)

RR (95% CI),

P Value


Primary:

IVD complications per patient, n (%)

64 (36%)

76 (41%)

RR 1.14 (0.88, 1.47),

p = 0.39

IVD complications per 1000 IVD days

66.0

(95% CI 49.8, 82.1)

67.8

(95% CI 52.6, 83.1)

HR 1.03 (0.74, 1.43),

p = 0.86

Secondary:

Phlebitis, n (%)

12 (7%)

18 (10%)

RR 1.44 (0.71, 2.89), p = 0.34

Infiltration, n (%)

53 (30%)

61 (33%)

RR 1.10 (0.81, 1.49), p = 0.57

Occlusion, n (%)

5 (3%)

4 (2%)

RR 0.77 (0.21, 2.80), p = 0.75

Accidental removal, n (%)

11 (6%)

16 (9%)

RR 1.39 (0.66, 2.92), p = 0.43

Local infection

0

0

-

IVD-related BSI, n (%)

0

0

-

IVD costs per patient,

AUD$ mean (SD)

$55.42 ($35.26)

$43.35

($26.78)

Mean difference

$12.07 (95%CI $5.57, $18.56), p < 0.001


Rickard et al. BMC Medicine 2010 8:53   doi:10.1186/1741-7015-8-53

Open Data